Australia's most trusted
source of pharma news
Posted 18 February 2026 PM
National Health and Medical Research Council (NHMRC) has endorsed a new consent form for trial participants designed to be clear and participant-centred.
Developed by CT:IQ (Clinical Trials: Impact & Quality), of which MA is an executive committee member, the new InFORMed Participant Information and Consent Form (PICF) template is flexible to allow researchers to think critically about which components need to be included, and which are not relevant to the trial being conducted.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.